Green tea extracts for the prevention of metachronous colorectal polyps among patients who underwent endoscopic removal of colorectal adenomas: A randomized clinical trial

被引:78
作者
Shin, Cheol Min [1 ]
Lee, Dong Ho [1 ]
Seo, A. Young [1 ,2 ]
Lee, Hyun Joo [1 ]
Kim, Seong Beom [1 ]
Son, Woo-Chan [3 ]
Kim, Young Kyung [4 ]
Lee, Sang Jun [4 ,5 ]
Park, Sung-Hee [4 ]
Kim, Nayoung [1 ]
Park, Young Soo [1 ]
Yoon, Hyuk [1 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, 173-82 Gumi Ro, Seongnam, Gyeonggi Do, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Hlth Promot Ctr, Chang Won, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea
[4] AmorePacific Co, R&D Ctr, Beauty Longev Sci Res Div, Yongin, Gyeonggi Do, South Korea
[5] Holist Bio Co, Gyeonggi Do, South Korea
关键词
Green tea; Epigallocatechin gallate; Colon polyps; Recurrence risk; COLON-CANCER CELLS; EGCG INHIBITS ACTIVATION; (-)-EPIGALLOCATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; PROSPECTIVE COHORT; RECEPTOR; EXPRESSION; CATECHINS; DISEASE; GROWTH;
D O I
10.1016/j.clnu.2017.01.014
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objectives: To determine the preventive effect of green tea extract (GTE) supplements on metachronous Materials and methods: One hundred seventy-six subjects (88 per each group) who had undergone complete removal of colorectal adenomas by endoscopic polypectomy were enrolled. They were rant domized into 2 groups: supplementation group (0.9 g GTE per day for 12 months) or control group without GTE supplementation. The 72-h recall method was used to collect data on food items consumed by participants at baseline and the 1-year follow-up during the past 48 h. Follow-up colonoscopy was conducted 12 months later in 143 patients (71 in control group and 72 in the GTE group). colorectal adenoma and cancer in the Korean population. Results: Of the 143 patients completed in the study, the incidences of metachronous adenomas at the end-point colonoscopy were 42.3% (30 of 71) in control group and 23.6% (17 of 72) in GTE group (relative risk [RR), 0.56; 95% confidence interval [CI], 0.34-0.92). The number of relapsed adenoma was also decreased in the GTE group than in the control group (0.7 +/- 1.1 vs. 0.3 +/- 0.6, p = 0.010). However, there: were no significant differences between the 2 groups in terms of body mass index, dietary intakes, serum lipid profiles, fasting serum glucose, and serum C-reactive protein levels (all p > 0.05). Conclusion: This study of GTE supplement suggests a favorable outcome for the chemoprevention of metachronous colorectal adenomas in Korean patients. (C) 2017 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
引用
收藏
页码:452 / 458
页数:7
相关论文
共 29 条
[1]   (-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells [J].
Adachi, Seiji ;
Shimizu, Masahito ;
Shirakami, Yohei ;
Yamauchi, Junichi ;
Natsume, Hideo ;
Matsushima-Nishiwaki, Rie ;
To, Satoshi ;
Weinstein, I. Bernard ;
Moriwaki, Hisataka ;
Kozawa, Osamu .
CARCINOGENESIS, 2009, 30 (09) :1544-1552
[2]   Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study [J].
Bettuzzi, S ;
Brausi, M ;
Rizzi, F ;
Castagnetti, G ;
Peracchia, G ;
Corti, A .
CANCER RESEARCH, 2006, 66 (02) :1234-1240
[3]   Green Tea and Anticancer Perspectives: Updates from Last Decade [J].
Butt, Masood Sadiq ;
Ahmad, Rabia Shabir ;
Sultan, M. Tauseef ;
Qayyum, Mir M. Nasir ;
Naz, Ambreen .
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2015, 55 (06) :792-805
[4]   Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity [J].
Chantre, P ;
Lairon, D .
PHYTOMEDICINE, 2002, 9 (01) :3-8
[5]   The Global Burden of Cancer 2013 Global Burden of Disease Cancer Collaboration [J].
Fitzmaurice, Christina ;
Dicker, Daniel ;
Pain, Amanda ;
Hamavid, Hannah ;
Moradi-Lakeh, Maziar ;
Maclntyre, Michael F. ;
Allen, Christine ;
Hansen, Gillian ;
Woodbrook, Rachel ;
Wolfe, Charles ;
Hamadeh, Randah R. ;
Moore, Ami ;
Werdecker, Andrea ;
Gessner, Bradford D. ;
Te Ao, Braden ;
McMahon, Brian ;
Karimkhani, Chante ;
Yu, Chuanhua ;
Cooke, Graham S. ;
Schwebel, David C. ;
Carpenter, David O. ;
Pereira, David M. ;
Nash, Denis ;
Kazi, Dhruv S. ;
De Leo, Diego ;
Plass, Dietrich ;
Ukwaja, Kingsley N. ;
Thurston, George D. ;
Jin, Kim Yun ;
Simard, Edgar P. ;
Mills, Edward ;
Park, Eun-Kee ;
Catala-Lopez, Ferran ;
DeVeber, Gabrielle ;
Gotay, Carolyn ;
Khan, Gulfaraz ;
Hosgood, H. Dean, III ;
Santos, Itamar S. ;
Leasher, Janet L. ;
Singh, Jasvinder ;
Leigh, James ;
Jonas, Jost B. ;
Sanabria, Juan ;
Beardsley, Justin ;
Jacobsen, Kathryn H. ;
Takahashi, Ken ;
Franklin, Richard C. ;
Ronfani, Luca ;
Montico, Marcella ;
Naldi, Luigi .
JAMA ONCOLOGY, 2015, 1 (04) :505-527
[6]  
Fujiki Hirota, 2015, J Cancer Prev, V20, P1
[7]   Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins [J].
Galati, G ;
Lin, A ;
Sultan, AM ;
O'Brien, PJ .
FREE RADICAL BIOLOGY AND MEDICINE, 2006, 40 (04) :570-580
[8]   Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence [J].
Hoensch, Harald ;
Groh, Bertram ;
Edler, Lutz ;
Kirch, Wilhelm .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (14) :2187-2193
[9]  
International Agency for Research on Cancer. GLOBOCAN, 2012, EST CANC INC MORT PR
[10]   Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: Dermal, acute and short-term toxicity studies [J].
Isbrucker, R. A. ;
Edwards, J. A. ;
Wolz, E. ;
Davidovich, A. ;
Bausch, J. .
FOOD AND CHEMICAL TOXICOLOGY, 2006, 44 (05) :636-650